Inmune Bio Files Proxy Statement Supplement
Ticker: INMB · Form: DEFA14A · Filed: Apr 25, 2025 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | DEFA14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, regulatory-filing
TL;DR
Inmune Bio dropped more proxy info for the May 28th shareholder meeting.
AI Summary
Inmune Bio, Inc. filed a Definitive Additional Materials (DEFA14A) on April 25, 2025, supplementing its proxy statement for the annual meeting of stockholders scheduled for May 28, 2025. The filing provides additional information to shareholders regarding matters to be voted on at the meeting, which was previously announced on April 21, 2025.
Why It Matters
This filing provides shareholders with updated information necessary to make informed decisions when voting at the upcoming annual meeting, impacting corporate governance and strategic direction.
Risk Assessment
Risk Level: low — This filing is a routine regulatory document providing additional materials for an upcoming shareholder meeting and does not contain new financial or operational risks.
Key Players & Entities
- Inmune Bio, Inc. (company) — Registrant
- May 28, 2025 (date) — Annual Meeting Date
- April 25, 2025 (date) — Filing Date
- April 21, 2025 (date) — Previous Announcement Date
FAQ
What type of filing is this DEFA14A for Inmune Bio, Inc.?
This is a Definitive Additional Materials filing, supplementing the proxy statement for the annual meeting of stockholders.
When is the annual meeting of stockholders for Inmune Bio, Inc. scheduled?
The annual meeting of stockholders is scheduled to be held on May 28, 2025.
On what date was this DEFA14A filing made?
The DEFA14A filing was made on April 25, 2025.
What does 'DEFA14A' stand for in the context of SEC filings?
DEFA14A stands for Definitive Additional Materials, which are filed under Schedule 14A, typically supplementing a proxy statement.
What was announced on April 21, 2025, related to this filing?
On April 21, 2025, Inmune Bio, Inc. made a previous announcement related to the proxy statement for the annual meeting of stockholders.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 25, 2025 regarding Inmune Bio, Inc. (INMB).